CDNA TRANSFECTION FOLLOWED BY THE ISOLATION OF A MCF-7 BREAST CELL-LINE RESISTANT TO TAMOXIFEN IN-VITRO AND IN-VIVO

被引:15
作者
TOI, M [1 ]
HARRIS, AL [1 ]
BICKNELL, R [1 ]
机构
[1] UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,IMPERIAL CANC RES FUND,MOLEC ONCOL LAB,OXFORD OX3 9DU,ENGLAND
关键词
D O I
10.1038/bjc.1993.486
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A tamoxifen resistant cell line (clone 9) has been isolated from the tamoxifen sensitive, hormone responsive MCF-7 breast carcinoma cell line after transfection with mixed cDNA libraries, followed by tamoxifen selection in the presence of oestrogens. Transfection was confirmed by Southern analysis with vector probes. Clone 9 in several-fold more resistant to tamoxifen and other anti-oestrogens than wild type cells when cultured either as a monolayer or as colonies in soft agar but retains oestrogen receptors. Clone 9 was less responsive to 17-beta-oestradiol than were wild type MCF-7. In addition to showing in vitro tamoxifen resistance, clone 9 was also tamoxifen resistant in vivo when xenografted into the nude mouse. Culture medium conditioned by clone 9 cells stimulated quiescent cells of the same clone as well as wild type cells, whereas medium conditioned by wild type MCF-7 was inhibitory to both, suggesting that clone 9 may be secreting an autocrine growth factor. Clone 9 provides a novel model for further investigation of the mechanism of anti-oestrogen resistance that occurs without loss of oestrogen receptors. Preliminary results suggest that an autocrine growth stimulatory mechanism may be one pathway of such resistance.
引用
收藏
页码:1088 / 1096
页数:9
相关论文
共 46 条
[11]   ANTIESTROGEN ICI-164,384 REDUCES CELLULAR ESTROGEN-RECEPTOR CONTENT BY INCREASING ITS TURNOVER [J].
DAUVOIS, S ;
DANIELIAN, PS ;
WHITE, R ;
PARKER, MG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :4037-4041
[12]  
GOTTARDIS MM, 1988, CANCER RES, V48, P5183
[13]  
GRAHAM ML, 1990, CANCER RES, V50, P6208
[14]   AMINOGLUTETHIMIDE FOR THE TREATMENT OF ADVANCED POST-MENOPAUSAL BREAST-CANCER [J].
HARRIS, AL ;
POWLES, TJ ;
SMITH, IE ;
COOMBES, RC ;
FORD, HT ;
GAZET, JC ;
HARMER, CL ;
MORGAN, M ;
WHITE, H ;
PARSONS, CA ;
MCKINNA, JA .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (01) :11-17
[15]  
HARRIS AL, 1989, EUR J CANCER CLIN ON, V27, P1108
[16]   TOWARDS A MOLECULAR-BASIS FOR TAMOXIFEN RESISTANCE IN BREAST-CANCER [J].
JOHNSTON, SRD ;
DOWSETT, M ;
SMITH, IE .
ANNALS OF ONCOLOGY, 1992, 3 (07) :503-511
[17]   TRANSFECTION OF V-RASH DNA INTO MCF-7 HUMAN-BREAST CANCER-CELLS BYPASSES DEPENDENCE ON ESTROGEN FOR TUMORIGENICITY [J].
KASID, A ;
LIPPMAN, ME ;
PAPAGEORGE, AG ;
LOWY, DR ;
GELMANN, EP .
SCIENCE, 1985, 228 (4700) :725-728
[18]   EVIDENCE THAT TRANSFORMING GROWTH-FACTOR-BETA IS A HORMONALLY REGULATED NEGATIVE GROWTH-FACTOR IN HUMAN-BREAST CANCER-CELLS [J].
KNABBE, C ;
LIPPMAN, ME ;
WAKEFIELD, LM ;
FLANDERS, KC ;
KASID, A ;
DERYNCK, R ;
DICKSON, RB .
CELL, 1987, 48 (03) :417-428
[19]   ESTROGEN-RECEPTOR STATUS AND ENDOCRINE THERAPY OF BREAST-CANCER - RESPONSE RATES AND STATUS STABILITY [J].
LEAKE, RE ;
LAING, L ;
CALMAN, KC ;
MACBETH, FR ;
CRAWFORD, D ;
SMITH, DC .
BRITISH JOURNAL OF CANCER, 1981, 43 (01) :59-66
[20]  
LIEN EA, 1989, CANCER RES, V49, P2175